MedTech News
.................... by Andrew Celentano
DNA shaper steers nervous system development
A study of worms finds a protein that helps shape the structure of the genome is critical for establishing the identity of some neurons.
Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval
Lantheus’s radiodiagnostic is designed to identify cognitively impaired patients who have tau neurofibrillary tangle (NFT) pathology.
OncoSil obtains FDA humanitarian exemption for bile duct cancer treatment
OncoSil’s device is designed for implantation into solid tumours via injection under endoscopic ultrasound guidance.
Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software
Johnson & Johnson MedTech (NYSE: JNJ) today announced the launch of Monarch Quest 3, the latest software iteration for its Monarch robotically assisted bronchoscopy platform.
Wearable smart patch could automatically deliver aid during a fentanyl overdose
A patch smaller than a penny could one day save the lives of people experiencing a fentanyl overdose—even when no one else is there to help.
New way to help CAR-T cells fight solid tumors could change cancer treatment
For more than a decade, CAR-T cell therapy has been one of the biggest breakthroughs in cancer medicine. By reprogramming a patient’s own immune cells to attack cancer, doctors have produced remarkable results against certain blood cancers, offering hope to patients who once had few treatment options.
Two devices in one: Metasurface could bring medical imaging to smaller sensors
Researchers have developed a technology for building more compact point-of-care medical imaging devices by creating a material that acts as two devices in one.
Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™
BALTIMORE, Aug. 14, 2026 /PRNewswire/ — Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá.